(9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene

C22H26O5 — CID 102424837

IUPAC(9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene
SMILESCOc1cc2c(cc1OC)-c1c(cc3c(c1OC)OCO3)C[C@@H](C)[C@@H](C)C2
InChIInChI=1S/C22H26O5/c1-12-6-14-8-17(23-3)18(24-4)10-16(14)20-15(7-13(12)2)9-19-21(22(20)25-5)27-11-26-19/h8-10,12-13H,6-7,11H2,1-5H3/t12-,13+/m0/s1
InChIKeyVGSPEFXOOQOBBF-QWHCGFSZSA-N
MW370.45 g/mol
LogP4.48
Rot. Bonds3

About (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene

(9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene (PubChem CID 102424837) has the molecular formula C22H26O5 and a molecular weight of 370.45 g/mol. Its IUPAC name is (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene.

Molecular Properties

Compound Name(9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene
PubChem CID102424837
Molecular FormulaC22H26O5
Molecular Weight370.45 g/mol
Exact Mass370.18
IUPAC Name(9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene
SMILESCOc1cc2c(cc1OC)-c1c(cc3c(c1OC)OCO3)C[C@@H](C)[C@@H](C)C2
InChIInChI=1S/C22H26O5/c1-12-6-14-8-17(23-3)18(24-4)10-16(14)20-15(7-13(12)2)9-19-21(22(20)25-5)27-11-26-19/h8-10,12-13H,6-7,11H2,1-5H3/t12-,13+/m0/s1
InChIKeyVGSPEFXOOQOBBF-QWHCGFSZSA-N
XLogP4.48
TPSA46.15 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500370.45
LogP ≤ 54.48
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene?
The IUPAC name of (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene (CID 102424837) is (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene.
What is the SMILES notation for (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene?
The canonical SMILES for (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene is COc1cc2c(cc1OC)-c1c(cc3c(c1OC)OCO3)C[C@@H](C)[C@@H](C)C2.
What is the InChIKey of (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene?
The InChIKey is VGSPEFXOOQOBBF-QWHCGFSZSA-N. The full InChI is InChI=1S/C22H26O5/c1-12-6-14-8-17(23-3)18(24-4)10-16(14)20-15(7-13(12)2)9-19-21(22(20)25-5)27-11-26-19/h8-10,12-13H,6-7,11H2,1-5H3/t12-,13+/m0/s1.
What are the key properties of (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene?
(9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene has a molecular weight of 370.45 g/mol, XLogP of 4.48, 3 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (9S,10R)-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene is sourced from PubChem (CID 102424837), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).